CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like Bioethicists Say Right-to-Try Legislation Will Have Minimal Effect on Drug Access January 15, 2018 Mylan, Sandoz, Teva and 10 Other Generics Makers Named in Six Price-Fixing Lawsuits June 6, 2017 FDA Cites Supplement Company for Drug Claims October 10, 2017
